Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Journal of Clinical Laboratory Analysis|December 10, 2019
Prognostic relevance of telomere length and telomerase reverse transcriptase variant (rs2242652) on the multiple myeloma patientsSalah Aref, Alshaimaa Al Saeed, Nadia El Menshawy, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 29, 2022
DNA Repair Genes Polymorphisms: Impact on Acute Myeloid Leukemia Patients OutcomeSalah Aref, Nadia El Menshawy, Tarek Abou Zeid, et al.
Cancer Biomarkers : Section a of Disease Markers|May 18, 2020
Clinical value of CD25/CD123 co-expression in acute myeloid leukemia patientsSalah Aref, Emaad Azmy, Doaa El Ghannam, et al.
Journal of Pediatric Hematology/Oncology|March 10, 2023
Significance of CEBPE Gene Promoter Polymorphism (Rs2239630 G > A ) Assessment in Childhood B-cell Acute Lymphoblastic LeukemiaSalah Aref, Mohamed El-Ghonemy, Hendawy Shimaa, et al.
Advances in Hematology|June 11, 2020
Clinical Impact of CD25/CD123 Coexpression in Adult B-Cell Acute Lymphoblastic Leukemia PatientsSalah Aref, Mohamed El Agdar, Nada Khaled, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 29, 2022
Clinical Implication of Toll-Like Receptors (TLR2 and TLR4) Polymorphisms in Adult Patients with Acute B-cell Lymphoblastic LeukemiaSalah Aref, Alshaimaa Abdelmaksoud, Sherin Abdellaziz, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 28, 2020
Impact of Bone Marrow Natural Killer Cells (NK); Soluble TNF-α and IL-32 Levels in Myelodysplastic Syndrome PatientsSalah Aref, Nada Khaled, Abdel Hady Al Gilany, et al.
ACS Omega|March 14, 2022
Diagnostic Value of 1H NMR-Based Metabolomics in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Breast CancerHanaa M Morad, Mohamed M Abou-Elzahab, Salah Aref, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 27, 2020
NOTCH-1 Gene Mutations Influence Survival in Acute Myeloid Leukemia PatientsSalah Aref, Rasha Rizk, Mohamed El Agder, et al.
Hematology (Amsterdam, Netherlands)|July 16, 2005
Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out comeSalah Aref, Mamdouh El Sherbiny, Tarek Goda, et al.
Pageof 8